Located at Pithampur in Madhya Pradesh.
Ipca Laboratories announced that the Company has acquired as a going concern on slump sale basis the High Potency Oral Solid Dosage formulations manufacturing unit situated at Pithampur in Madhya Pradesh.This manufacturing unit has the approval of the WHO-GMP and INVIMA Colombai and was also recently inspected by German Regulatory Agency and their approval is pending.
This acquisition will help the Company in forward integrating the hormonal APIs being manufactured by the Company at its manufacturing unit situated at Nandesari with hormonal formulation for the world markets.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app